Results for tag: "Cardiometabolic Disease Drug"

The Cardiometabolic Disease Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat cardiometabolic diseases such as diabetes, obesity, and dyslipidemia. These drugs are used to reduce the risk of cardiovascular events, such as heart attack and stroke, by controlling blood sugar, cholesterol, and triglyceride levels. Commonly prescribed drugs include statins, ACE inhibitors, and GLP-1 agonists. The Cardiometabolic Disease Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, Novartis, Sanofi, Merck, and AstraZeneca. Show Less Read more